Institutional Ownership Candel Therapeutics, Inc. (CADL)
This table provides information about the institutional ownership of Candel Therapeutics, Inc. (CADL). We have compiled data on the 84 institutions that hold shares in the stock, with a total of 15.3 Million shares, which have been reported (via 13F filing form) to have a value of $77.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nisa Investment Advisors, LLC
|
Jul 31, 2025 Q2 2025 |
48
shares
|
$242
0.0% of portfolio
|
Q2 2025
Added 9.09%
|
|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
33
shares
|
$166
0.0% of portfolio
|
Q2 2025
Reduced 82.26%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Aug 07, 2025 Q2 2025 |
20
shares
|
$101
0.0% of portfolio
|
Q2 2025
Added 100.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|